Who
Diane E. Sullivan
Director
Company insider
Files Form 4 as: Director, Lexicon Pharmaceuticals; Director, Amarin Corporation.
In numbers
- Trades disclosed
- 30
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 21 Jul 2023
- Last trade
- 3 Jun 2026
- Last filed
- 4 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Jun 2026filed 4 Jun 2026 | LXRX Lexicon PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —89,312 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | LXRX Lexicon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —89,312 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | LXRX Lexicon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —89,312 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | LXRX Lexicon PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —89,312 at $0.00 | filing |
| 1 May 2026filed 4 May 2026 | LXRX Lexicon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,714 at $0.00 | filing |
| 1 May 2026filed 4 May 2026 | LXRX Lexicon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —43,478 at $0.00 | filing |
| 1 May 2026filed 4 May 2026 | LXRX Lexicon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,714 at $0.00 | filing |
| 1 May 2026filed 4 May 2026 | LXRX Lexicon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —43,478 at $0.00 | filing |
| 18 Apr 2026filed 21 Apr 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —838 | filing |
| 18 Apr 2026filed 21 Apr 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $6,037403 at $14.98 | filing |
| 18 Apr 2026filed 21 Apr 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —838 at $0.00 | filing |
| 18 Apr 2026filed 21 Apr 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —838 at $0.00 | filing |
| 18 Apr 2026filed 21 Apr 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —838 | filing |
| 18 Apr 2026filed 21 Apr 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $6,037403 at $14.98 | filing |
| 3 Jun 2025filed 3 Jun 2025 | LXRX Lexicon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —103,806 at $0.00 | filing |
| 3 Jun 2025filed 3 Jun 2025 | LXRX Lexicon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —89,312 at $0.00 | filing |
| 13 May 2025filed 13 May 2025 | LXRX Lexicon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —36,810 at $0.00 | filing |
| 13 May 2025filed 13 May 2025 | LXRX Lexicon PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —36,810 at $0.00 | filing |
| 18 Apr 2025filed 22 Apr 2025 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —838 at $0.00 | filing |
| 18 Apr 2025filed 22 Apr 2025 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —838 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.